Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clara Hwang

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
JAMA Network Open|January 26, 2021
Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical TrialUlka N Vaishampayan, Lance K Heilbrun, Paul Monk, et al.
Plos One|March 24, 2012
Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIMDejuan Kong, Elisabeth Heath, Wei Chen, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 28, 2025
Increasing Prostate Cancer Education and Screening for Black Men in Southeastern Michigan: Your Prostate, Your HealthShane A Tinsley, Doreen Dankerlui, Camille Romain, et al.
Cancer Reports (Hoboken, N.J.)|May 20, 2021
Rapid real-world data analysis of patients with cancer, with and without COVID-19, across distinct health systemsClara Hwang, Monika A Izano, Michael A Thompson, et al.
European Urology Oncology|September 22, 2024
American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local Intraprostatic Recurrence of Prostate Cancer Following Definitive RadiotherapyLuca F Valle, Tommy Jiang, Ashton Rosenbloom, et al.
Scientific Reports|January 8, 2025
Barriers to orthodox medical care of prostate cancer in GhanaPatrick Opoku Manu Maison, Prince Arkoh, Ahmed Sani, et al.
Cancer Research Communications|June 10, 2024
Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate-Resistant Prostate CancerElisabeth I Heath, Archana Thakur, Wei Chen, et al.
Research Square|August 23, 2023
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaborationTanya Dorff, Zeynep Zengin, Nicholas Henderson, et al.
European Urology|June 26, 2026
Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management ImplicationsCan Aydogdu, Laura Bukavina, Liang Cheng, et al.
Neoplasia (New York, N.Y.)|August 26, 2019
Pseudogene Associated Recurrent Gene Fusion in Prostate CancerBalabhadrapatruni Vsk Chakravarthi, Pavithra Dedigama-Arachchige, Shannon Carskadon, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
JAMA Network Open|January 26, 2021
Clinical Efficacy of Enzalutamide vs Bicalutamide Combined With Androgen Deprivation Therapy in Men With Metastatic Hormone-Sensitive Prostate Cancer: A Randomized Clinical TrialUlka N Vaishampayan, Lance K Heilbrun, Paul Monk, et al.
Plos One|March 24, 2012
Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIMDejuan Kong, Elisabeth Heath, Wei Chen, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|February 28, 2025
Increasing Prostate Cancer Education and Screening for Black Men in Southeastern Michigan: Your Prostate, Your HealthShane A Tinsley, Doreen Dankerlui, Camille Romain, et al.
Cancer Reports (Hoboken, N.J.)|May 20, 2021
Rapid real-world data analysis of patients with cancer, with and without COVID-19, across distinct health systemsClara Hwang, Monika A Izano, Michael A Thompson, et al.
European Urology Oncology|September 22, 2024
American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local Intraprostatic Recurrence of Prostate Cancer Following Definitive RadiotherapyLuca F Valle, Tommy Jiang, Ashton Rosenbloom, et al.
Scientific Reports|January 8, 2025
Barriers to orthodox medical care of prostate cancer in GhanaPatrick Opoku Manu Maison, Prince Arkoh, Ahmed Sani, et al.
Cancer Research Communications|June 10, 2024
Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate-Resistant Prostate CancerElisabeth I Heath, Archana Thakur, Wei Chen, et al.
Research Square|August 23, 2023
Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaborationTanya Dorff, Zeynep Zengin, Nicholas Henderson, et al.
European Urology|June 26, 2026
Histological Subtypes and Divergent Differentiation of Urothelial Carcinoma: Histology, Genomics, and Management ImplicationsCan Aydogdu, Laura Bukavina, Liang Cheng, et al.
Neoplasia (New York, N.Y.)|August 26, 2019
Pseudogene Associated Recurrent Gene Fusion in Prostate CancerBalabhadrapatruni Vsk Chakravarthi, Pavithra Dedigama-Arachchige, Shannon Carskadon, et al.
Pageof 9